On 21 June 2010, the Urgo Corporate Foundation was delighted to hand over a cheque to the value of 30,000 euros to the epidermolysis patient association: the EBAE.
At the event, hosted by the MAGEC. (Maladie Génétique à Expression Cutanée, or the Genetic Skin Diseases) Department at the Necker Hospital in Paris, a cheque was handed over by Pierre Moustial (CEO of Urgo Laboratories) and Catherine Salomon (Urgo Foundation Project Officer) to Guy Verdot (Vice-president of the Association) in the presence of Professors Christine Bodemer, Paediatric Dermatologist and Coordinator of the MAGEC Reference Centre and Alain Hovnanian.
The money allocated by the Urgo Foundation will be go directly to the two research platforms: Archet Hospital (Nice) and Necker Hospital (Paris). The contribution will fund continued research in the field of epidermolysis bullosa (EB) via the design of a first gene therapy trial, the creation of a biotherapy laboratory and the recruitment of personnel to reinforce dedicated teams.
To find out more, go to the Experts Views section and read the interview with Guy Verdot.
